NO20030518D0 - Farmasöytisk preparat som omfatter metformin og et derivat av 5-fenoksyalkyl-2,4-tiazolidindion-type - Google Patents

Farmasöytisk preparat som omfatter metformin og et derivat av 5-fenoksyalkyl-2,4-tiazolidindion-type

Info

Publication number
NO20030518D0
NO20030518D0 NO20030518A NO20030518A NO20030518D0 NO 20030518 D0 NO20030518 D0 NO 20030518D0 NO 20030518 A NO20030518 A NO 20030518A NO 20030518 A NO20030518 A NO 20030518A NO 20030518 D0 NO20030518 D0 NO 20030518D0
Authority
NO
Norway
Prior art keywords
phenoxyalkyl
metformin
pharmaceutical composition
type derivative
thiazolidinedione type
Prior art date
Application number
NO20030518A
Other languages
English (en)
Other versions
NO20030518L (no
Inventor
Gerard Moinet
Gerard Botton
Didier Mesangeau
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20030518D0 publication Critical patent/NO20030518D0/no
Publication of NO20030518L publication Critical patent/NO20030518L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20030518A 2000-08-04 2003-02-03 Farmasöytisk preparat som omfatter metformin og et derivat av 5-fenoksyalkyl-2,4-tiazolidindion-type NO20030518L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0010362A FR2812547B1 (fr) 2000-08-04 2000-08-04 Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
PCT/EP2001/008512 WO2002011721A1 (en) 2000-08-04 2001-07-24 Pharmaceutical composition comprising metformin and a 5-phenoxyalkyl-2,4-thiazolidinedione-type derivative

Publications (2)

Publication Number Publication Date
NO20030518D0 true NO20030518D0 (no) 2003-02-03
NO20030518L NO20030518L (no) 2003-02-03

Family

ID=8853342

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030518A NO20030518L (no) 2000-08-04 2003-02-03 Farmasöytisk preparat som omfatter metformin og et derivat av 5-fenoksyalkyl-2,4-tiazolidindion-type

Country Status (19)

Country Link
US (1) US20040014797A1 (no)
EP (1) EP1305025A1 (no)
JP (1) JP2004505915A (no)
KR (1) KR20030019470A (no)
CN (1) CN1446090A (no)
AR (1) AR030309A1 (no)
AU (1) AU2001282010A1 (no)
BR (1) BR0112915A (no)
CA (1) CA2417883A1 (no)
CZ (1) CZ2003476A3 (no)
EC (1) ECSP034463A (no)
FR (1) FR2812547B1 (no)
HU (1) HUP0303684A2 (no)
MX (1) MXPA03000975A (no)
NO (1) NO20030518L (no)
PL (1) PL358791A1 (no)
RU (1) RU2003105809A (no)
SK (1) SK2082003A3 (no)
WO (1) WO2002011721A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003105809A1 (en) 2002-06-17 2003-12-24 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
UA80991C2 (en) * 2002-10-07 2007-11-26 Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
WO2008016729A1 (en) * 2006-08-04 2008-02-07 Nastech Pharmaceutical Company Inc. Compositions for intranasal delivery of human insulin and uses thereof
CN105152983A (zh) * 2007-01-29 2015-12-16 韩诺生物制药株式会社 N,n-二甲基亚氨基二碳亚氨酸二酰胺乙酸盐、其制备方法和包含其的药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2749583B1 (fr) * 1996-06-07 1998-08-21 Lipha Nouveaux derives de thiazolidine -2,4- dione substitues, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
ATE355840T1 (de) * 1997-06-18 2007-03-15 Smithkline Beecham Plc Behandlung der diabetes mit thiazolidindione und metformin
GB9715295D0 (en) * 1997-07-18 1997-09-24 Smithkline Beecham Plc Novel method of treatment

Also Published As

Publication number Publication date
EP1305025A1 (en) 2003-05-02
CZ2003476A3 (cs) 2003-06-18
RU2003105809A (ru) 2004-08-27
HUP0303684A2 (hu) 2004-03-01
WO2002011721A1 (en) 2002-02-14
PL358791A1 (en) 2004-08-23
FR2812547A1 (fr) 2002-02-08
CN1446090A (zh) 2003-10-01
CA2417883A1 (en) 2002-02-14
FR2812547B1 (fr) 2002-10-31
SK2082003A3 (en) 2003-07-01
KR20030019470A (ko) 2003-03-06
JP2004505915A (ja) 2004-02-26
MXPA03000975A (es) 2003-06-09
AR030309A1 (es) 2003-08-20
US20040014797A1 (en) 2004-01-22
ECSP034463A (es) 2003-03-31
BR0112915A (pt) 2003-07-08
NO20030518L (no) 2003-02-03
AU2001282010A1 (en) 2002-02-18

Similar Documents

Publication Publication Date Title
NO20025879D0 (no) Acylfenylureaderivater, fremgangsmåte for fremstilling derav og deres anvendelse som et legemiddel
DK1343777T3 (da) Methansulfonamido-benzofuranderivat, fremgangsmåde til dets fremstilling og dets anvendelse som syntesemellemprodukt
DK1218341T3 (da) Sulfonylcarboxamid-derivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
NO20032842L (no) Karbazolderivater og deres anvendelse som neuropeptid Y5- reseptor-ligander
NO20033726L (no) Xantin-derivater, fremstilling og anvendelse derav som et medikament
NO20031744L (no) Nye ikke-imadazolforbindelser og farmasöytisk preparat omfattende slike
DK1301485T3 (da) Nye heteroaryl-derivater og disses anvendelse som lægemiddel
DK1381605T3 (da) Mercaptoacetylamidderivater, en fremgangsmåde til deres fremstilling og deres anvendelse
DK1311285T3 (da) Flydende farmaceutisk præparat, som omfatter et erythropoietinderivat
NO20024175L (no) Azetidinderivater, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
NO20021719D0 (no) 6-posisjon substituerte indoliner, fremstilling og anvendelse derav som medikament
NO20030418D0 (no) Nytt farmasöytisk preparat
DK1309317T3 (da) Farmaceutiske præparater, der omfatter amlodipinmaleat
NO20044322L (no) Benzoksanon-avledede forbindelser, deres fremstilling og anvendelse som medikament
NO20042635L (no) 5-Sulfanyl-ñH-1,2,4-triazol-derivater og deres anvendelse som medisin
DK1235558T3 (da) Sammenpresset tabletsammensætning, der omfatter et NSAID
DK1322158T3 (da) Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf
NO20013900D0 (no) Epotilonderivater, fremgangsmate og anvendelse derav som legemiddel
DK1173434T3 (da) Thiazolidindionderivat og dets anvendelse som antidiabetisk middel
NO20001905L (no) (Poly)tiaalkynforbindelser og deres derivater, preparater omfattende disse og deres anvendelse
DK1231211T3 (da) Thiazolidindion-derivater som antidiabetika
NO20030518D0 (no) Farmasöytisk preparat som omfatter metformin og et derivat av 5-fenoksyalkyl-2,4-tiazolidindion-type
DK1173436T3 (da) Thiazolidindionderivat og anvendelse deraf som antidiabetikum
DK1053224T3 (da) Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel
DK1157020T3 (da) Substituerede 1,2,3,4,5,6-hexahydro-2,6-methano-2-benzazocin-10-oler, fremgangsmåder til deres fremstilling og deres anvendelse som lægemiddel

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application